Evidence map›Paper›PMID 39610594›Full record

ArticleCureus2024

Urothelial Carcinoma With Divergent Glandular Differentiation.

Hristo Popov, Andreya Kirilova, Kristina Naydenova, Ekaterina Softova, George S Stoyanov

Abstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hristo PopovGeneral and Clinical Pathology, Forensic Medicine and Deontology, Medical University of Varna, Varna, BGR.
Andreya KirilovaGeneral and Clinical Pathology, Forensic Medicine and Deontology, Medical University of Varna, Varna, BGR.
Kristina NaydenovaGeneral and Clinical Pathology, Forensic Medicine and Deontology, Medical University of Varna, Varna, BGR.
Ekaterina SoftovaPathology, Individual Medical Diagnostic Laboratory City Lab, Varna, BGR.
George S StoyanovPathology, Multiprofile Hospital for Active Treatment, Shumen, BGR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Divergent differentiation in urothelial carcinoma is a challenging phenomenon that often makes the proper histopathological diagnosis a challenge. Conventional foci are often scarce in this subclass of urothelial carcinoma, and even if proper grossing and slide processing is performed, inexperienced pathologists can miss them. Furthermore, divergent differentiation in urothelial carcinoma is important to be recognized as such not only for the true diagnosis to be established and hence not increase the statistical incidence of rare neoplasms but also as divergent differentiation is one of the key factors in defining urothelial carcinomas as high-grade and hence crucial for proper patient management and treatment. Herein, we report a histopathological case of a male patient in his 60s who had been diagnosed with a high-grade urothelial carcinoma with submucosal involvement one year prior. Due to symptom recurrence, a follow-up endoscopy and resection of suspicious areas were performed to check for disease recurrence. Histopathology revealed a malignant neoplasm with histomorphological features of predominantly colonic-type adenocarcinoma and only a few areas with urothelial papillary morphology. Hence, divergent differentiation of the neoplasm was noted. Other than not falsely increasing the incidence of rare bladder malignancies, proper recognition of urothelial divergent differentiation is also important for excluding metastatic lesions to the bladder, as most of the diverging types of differentiation are common in neighboring organs or in tumor types that have pronounced metastatic potential.

Indexed as

adenocarcinomadivergent differentiationmalignancy recurrenceurinary bladderurothelial carcinoma

Identifiers

PMID39610594
PMCPMC11604244

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.